Clearmind Medicine Inc (NASDAQ:CMND) price on Friday, March 21, fall -4.27% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $1.12.
A look at the stock’s price movement, the close in the last trading session was $1.17, moving within a range at $1.1 and $1.2976. The beta value (5-Year monthly) was -1.462. Turning to its 52-week performance, $2.30 and $0.95 were the 52-week high and 52-week low respectively. Overall, CMND moved -12.50% over the past month.
Clearmind Medicine Inc’s market cap currently stands at around $5.75 million, with investors looking forward to this quarter’s earnings report slated for in April.
Turning to the stock’s technical picture we see that short term indicators suggest on average that CMND is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
CMND’s current price about -3.56% and -14.88% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 40.90, while 7-day volatility ratio is 7.69% and 6.12% in the 30-day chart. Further, Clearmind Medicine Inc (CMND) has a beta value of -1.44, and an average true range (ATR) of 0.08.
If we refocus on Clearmind Medicine Inc (NASDAQ:CMND), historical trading data shows that trading volumes averaged 78200.0 over the past 10 days and 1.04 million over the past 3 months. The company’s latest data on shares outstanding shows there are 4.69 million shares.
The 5.97% of Clearmind Medicine Inc’s shares are in the hands of company insiders while institutional holders own 19.33% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 0.26 million on 2025-02-28, giving us a short ratio of 3.19. The data shows that as of 2025-02-28 short interest in Clearmind Medicine Inc (CMND) stood at 565.00003 of shares outstanding, with shares short falling to 0.33 million registered in 2025-01-31. Current price change has pushed the stock -18.84% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the CMND stock continues to rise going into the next quarter.
